L4C-62607-22235 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-28
Dose 1 — Pfizer-BioNTech
2022-01-24
Dose 2 — Pfizer-BioNTech
2022-04-18
Registered in v-safe
2022-04-25
Survey response — 3 months, dose 2, dependent
MedDRA: Febrile convulsion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Febrile seizure

MedDRA releases: 2024-11 · check-in free text available
2022-04-25
Report sent to call center — 3 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-04-26
Call successful
Participant prefers to complete VAERS report online
2022-07-27
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-28	Pfizer-BioNTech	No
2	2022-01-24	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-04-25	Successful 2022-04-26	Participant prefers to complete VAERS report online

Free text

Release 11 — 3 months, dose 2, dependent

2022-04-25

Symptoms: Febrile seizure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Febrile convulsion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release